Nyheter m m


Swedish Orphan Biovitrum AB15 min. fördröjning

Förändring-0.20% Senast174,60 SEK
Köp Sälj Läs mer

Swedish Orphan Biovitrum AB: Invitation - Presentation of Sobis Q1 2019 results

10:00 On 25 April, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi) will publish its report for the fourth quarter and full year 2018. Financial analysts and media are invited to participate in a telephone conference, which will include a presentation of the results, on the same day at 10:00 am CET. The event will be hosted by Sobis CEO and President, Guido Oelkers, and the presentation will be held in English. The presentation can be followed live, or afterwards on www.sobi.com. Slides used in the presentation will be made available on Sobis website prior to the telephone conference. To participate in the telephone conference, please call: SE: +46 8 505 583 69 UK: +44 33 330 090 35 US: +1 646 722 49 57 Click here to go to the live webcast. (http://event.on24.com/wcc/r/1977684-1/1B343F329AF97C6D4241519D7764BF15?partnerref=rss-events) After the live event the webcast will be available on-demand via the same URL. --- About Sobi At Sobi, we are transforming the lives of people affected by rare diseases. As a specialised international biopharmaceutical company, we provide sustainable access to innovative therapies in the areas of haematology, immunology and specialty care. We bring something rare to rare diseases - a belief in the strength of focus, the power of agility and the potential of the people we are dedicated to serving. The hard work and dedication of our approximately 1050 employees around the globe has been instrumental in our success across Europe, North America, the Middle East, Russia and North Africa, leading to total revenues of SEK 9.1 billion in 2018. Sobis share (STO:SOBI) is listed on Nasdaq Stockholm. You can find more information about Sobi at www.sobi.com. For more information please contact Media relations/Investor Investor relations relations Linda Holmström, Senior Jörgen Winroth, Senior IR Advisor Communications/IR Manager +46 708 734 095 +1 347 224 0819, +1 212 579 0506 linda.holmstrom@sobi.com jorgen.winroth@sobi.com Paula Treutiger, Head of Communications & Investor Relations +46 733 666 599 paula.treutiger@sobi.com Swedish Orphan Biovitrum AB (publ) Postal address SE-112 76 Stockholm, Sweden Phone: 46 8 697 20 00 www.sobi.com ----------------------------------------------------------- https://news.cision.com/swedish-orphan-biovitrum-ab/r/invitation---presentation-of-sobi-s-q1-2019-results,c2787843 https://mb.cision.com/Main/14266/2787843/1025074.pdf © Cision

Finansiella instrument kan både öka och minska i värde. Det finns en risk att du inte får tillbaka de pengar du investerar. Innan du investerar i en fond bör du läsa informationsbroschyren som finns hos fondbolaget och faktabladet som du hittar i orderläggningsfönstret samt på fondens produktsida på nordnet.se.